Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial — Jianxing He (2021) | RDL Network
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
Thomas Yau, Joong‐Won Park, Richard S. Finn, Ann‐Lii Cheng, Philippe Mathurin, Julien Edeline, Masatoshi Kudo, James J. Harding, Philippe Merle, Olivier Rosmorduc, Lucjan Wyrwicz, Eckart Schott, Su Pin Choo, Robin Kate Kelley, Wolfgang Sieghart, Éric Assenat, Renata Zaucha, Junji Furuse, Ghassan K. Abou‐Alfa, Anthony B. El-Khoueiry, Ignacio Melero, Damir Begic, Gong Chen, Jaclyn Neely, Tami Wisniewski, Marina Tschaika, Bruno Sangro
Arndt Vogel, Shukui Qin, Masatoshi Kudo, Yun Su, Stacie Hudgens, Tatsuya Yamashita, Jung‐Hwan Yoon, Lætitia Fartoux, Krzysztof Simon, Carlos López, Max W. Sung, Kalgi Mody, Tatsuroh Ohtsuka, Toshiyuki Tamai, L. Michelle Bennett, Genevieve Meier, В. В. Бредер
Vassilis Georgoulias, Ch Kourousis, N. Androulakis, S. Kakolyris, Meletios A Dimopoulos, E. Papadakis, Demosthenes Bouros, F Apostolopoulou, C Papadimitriou, Athina Agelidou, V Tzianni, F Apostolaki, Kostas Hatzakis, K. Kalbakis, Α. Kotsakis, E. Sarra, N. Vardakis, J. Vlachonicolis
Vassilis Georgoulias, Charalambos Kouroussis, N. Androulakis, S. Kakolyris, Meletios A Dimopoulos, E. Papadakis, Demosthenes Bouros, F Apostolopoulou, Christos Papadimitriou, Athina Agelidou, Kostas Hatzakis, Kostas Kalbakis, Αthanasios Kotsakis, N. Vardakis, J. Vlachonicolis
Discussion(0)
No comments yet. Be the first to comment.